KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) EPS (Basic) (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed EPS (Basic) for 4 consecutive years, with -$11.96 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, EPS (Basic) rose 75.57% year-over-year to -$11.96, compared with a TTM value of -$18.37 through Dec 2023, up 63.37%, and an annual FY2025 reading of -$5.64, up 46.49% over the prior year.
  • EPS (Basic) was -$11.96 for Q4 2023 at Ginkgo Bioworks Holdings, down from -$6.21 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.03 in Q3 2020 and bottomed at -$48.96 in Q4 2022.
  • Average EPS (Basic) over 4 years is -$5.17, with a median of -$0.39 recorded in 2022.
  • Peak annual rise in EPS (Basic) hit 83.47% in 2022, while the deepest fall reached 4084.62% in 2022.
  • Year by year, EPS (Basic) stood at -$0.04 in 2020, then plummeted by 2825.0% to -$1.17 in 2021, then crashed by 4084.62% to -$48.96 in 2022, then soared by 75.57% to -$11.96 in 2023.
  • Business Quant data shows EPS (Basic) for DNA at -$11.96 in Q4 2023, -$6.21 in Q3 2023, and -$0.09 in Q2 2023.